All Stories

  1. Emergency department crowding: How valuable is GPs information?
  2. Optimal consumption, portfolio, and long‐term‐care health insurance in a dynamic framework
  3. Spatial Competition Across Borders: The Role of Patients’ Mobility and Institutional Settings
  4. Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment
  5. Tax evasion and debt dynamics with endogenous growth
  6. Shadow Economy and Corruption
  7. The trade off between lower prices and availability of new drugs
  8. The role of competition and price in the decision o to invest in drug personalisation.
  9. Is it worth to create hospital care market where public providers compete with private one?
  10. Analysis of the price for new drugs that reflect their effectiveness
  11. Decentralisation and waste flows: A welfare approach
  12. The redistributive effects of copayment (superticket): evidence from Lombardy
  13. Claims for devoluton may be driven by a reduction in regional income redistribution?
  14. Regulation strategies for the provision of goods Governmment make affordable to all the population
  15. Rationing in health care provision: a welfare approach
  16. Patient mobility and health care quality when regions and patients differ in income
  17. The Dynamics of Pharmaceutical Regulation and R&D Investments
  18. Optimal dynamic tax evasion: A portfolio approach
  19. Devolution and grant-in-aid design for the provision of impure public goods
  20. Patient mobility in the context of austerity and an enlarged EU: The European Court of Justice's ruling in the Petru Case
  21. Tax evasion and uncertainty in a dynamic context
  22. Drug Prices and Incentives to Innovation by the Pharmaceutical Industry
  23. A hedonic price analysis for the Italian wine in the domestic market
  24. Editorial Note
  25. Patient mobility, health care quality and welfare
  26. Should I pay for your risky behaviours? Evidence from London
  27. Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria
  28. Health care expenditure decisions in the presence of devolution and equalisation grants
  29. Erratum to: Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study
  30. Two-part payments for the reimbursement of investments in health technologies
  31. Determinants of the price for the Italian red wine
  32. Pricing schemes for new drugs: A welfare analysis
  33. Health Care Provision and Patient Mobility
  34. Imperial College London Business School Questionnaire
  35. Patients’ Mobility Across Borders: A Welfare Analysis
  36. Cross Border Health Care Provision: Who Gains, Who Loses
  37. Optimal dynamic tax evasion
  38. Definition of a prospective payment system to reimburse emergency departments
  39. Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study
  40. Patient selection in a mixed oligopoly market for health care: the role of the soft budget constraint
  41. Tax audits, fines and optimal tax evasion in a dynamic context
  42. Soft budget constraints in health care: evidence from Italy
  43. Not a good buy: Value for money of prescription drugs sold on the Internet
  44. Rent Extraction through Alternative Forms of Competition in the Provision of Paternalistic Goods
  45. Pricing strategies for Italian red wine
  46. From local to global public goods: How should externalities be represented?
  47. Emotional decision-makers and anomalous attitudes towards information
  48. Strategic costs and preferences revelation in the allocation of resources for health care
  49. Consequences on welfare of using health care restrictions
  50. Marketing and pricing strategies of online pharmacies
  51. Investment decisions in hospital technology when physicians are devoted workers
  52. Emotions in physician agency
  53. INVESTMENT IN HOSPITAL CARE TECHNOLOGY UNDER DIFFERENT PURCHASING RULES: A REAL OPTION APPROACH
  54. EXIT, CHOICE OR LOYALTY: PATIENT DRIVEN COMPETITION IN PRIMARY CARE
  55. Tax Evasion and the Cost of Public Sector Activities
  56. Regulating internal markets for hospital care
  57. Il costo del diabete: l’esperienza dell’ASL di Brescia
  58. Public Health Care with Waiting Time Revisited
  59. Hospital Health Care: Pricing and Quality Control in a Spatial Model with Asymmetry of Information
  60. Patients' migration across regions: the case of Italy
  61. Optimal payment schemes for physicians
  62. Decentralized Budgeting Procedures for Public Expenditure
  63. Pricing Policies in the Pharmaceutical Sector
  64. The provision of impure public goods in a non-competitive market
  65. Does Government Expenditure Crowd Out Private Consumption in Italy? Evidence from a Microeconomic Model
  66. The Effect of Deficit in a Multicountry Model with Perfect Mobility of Capital
  67. Developments in Local Government Finance: Theory and Policy
  68. NHS contracts: An agency approach
  69. ACCOUNTABILITY AND THE INTERNAL MARKET
  70. The estimation of British local government expenditure decisions under a piecewise linear budget constraint
  71. Fiscal Autonomy, Grants-in-Aid and Expenditure of Local Governments
  72. Optimizing the level of grant support for local government: An application of a behavioral model
  73. Asymmetry of Information in Public Finance
  74. LOCAL AUTHORITY EXPENDITURE DECISIONS: A MAXIMUM LIKELIHOOD ANALYSIS OF BUDGET SETTING IN THE FACE OF PIECEWISE LINEAR BUDGET CONSTRAINTS *
  75. ACCOUNTABILITY AND THE POLL TAX: THE IMPACT ON LOCAL AUTHORITY BUDGETS OF THE REFORM OF LOCAL GOVERNMENT FINANCE IN ENGLAND
  76. ACCOUNTABILITY AND THE POLL TAX: THE IMPACT ON LOCAL AUTHORITY BUDGETS OF THE REFORM OF LOCAL GOVERNMENT FINANCE IN ENGLAND
  77. An incremental budgeting model of local public expenditure setting in the presence of piecewise linear budget constraints
  78. Does the flypaper model stick? A test of the relative performance of the flypaper and conventional models of local government budgetary behaviour
  79. An Assessment of the Regional Impact of the Introduction of a Community Charge (or Poll Tax) in England
  80. The Impact of Party Politics on Patterns of Service Provision in English Local Authorities
  81. Regulation Strategies for Public Service Provision
  82. Waste Disposal and Decentralisation: A Welfare Approach
  83. Optimal Copayment Strategies in a Public Health Care System
  84. Dutch First Price Auctions for Public Service Provision
  85. Regulation Strategies in the Provision of Health Care
  86. Drug Pricing in a Regulated Market
  87. Impure Public Goods Provision in a Federal Fiscal System
  88. Optimal Dynamic Tax Evasion: A Portfolio Approach
  89. Public Sector Cost Inflation through Tax Evasion
  90. Optimal Dynamic Tax Evasion: A Portfolio Approach
  91. La Nuova Riforma Federalista
  92. Drug Pricing and Risk Sharing Agreements
  93. Strategic Costs and Preferences Revelation in the Allocation of Resources for Medical Treatments
  94. Rent Extraction Through Alternative Forms of Competition in the Provision of Merit and Impure Public Goods
  95. Welfare Properties of Restrictions to Health Care Services Based on Cost Effectiveness
  96. Fiscal Federalism and Grant-in-Aid Design for the Provision of Impure Public Goods
  97. Patients' Migration Across Regions: The Case of Italy
  98. Exit, Choice or Loyalty: Patient Driven Competition in Primary Care
  99. Hospital Care Organisation in Italy: A Theoretical Assessment of the Reform
  100. Pricing Drugs in a Regulated Market: A Bargaining Approach
  101. The Dynamics of Pharmaceutical Regulation and R&D Investments
  102. Public Expenditure Determination in a Mixed Market for Health Care
  103. Horizontal and Vertical Cream Skimming in the Health Care Market
  104. A Taxonomy of Cream Skimming in the Provision of Hospital Care
  105. Grants in Aid to Local Government: Median Voter and Political Biases
  106. Paternalistic Goods to Improve Income Distribution: A Political Economy Approach
  107. Hedonic Price for the Italian Red Wine: A Panel Analysis
  108. Soft Budget Constraint in Health Care: Evidence from Italy
  109. Hedonic Price for the Italian Red Wine: A Panel Analysis
  110. Fiscal Federalism, Patient Mobility and the Soft Budget Constraint
  111. From Local to Global Public Goods: How Should We Write the Utility Function
  112. Investment in Hospital Care Technology Under Different Purchasing Rules: A Real Option Approach
  113. Hospital Health Care: Cost Reimbursement and Quality Control in a Spatial Model with Asymmetry of Information
  114. Internal markets for hospital care: cost and quality control in a spatial competition model
  115. Quality and Investment Decisions in Hospital Care when Physicians are Devoted Workers
  116. It Takes Three to Tango: Soft Budget Constraint and Cream Skimming in the Hospital Care Market
  117. Static and Dynamic Efficiency of Irreversible Health Care Investments Under Alternative Payment Rules
  118. Static and Dynamic Efficiency of Irreversible Health Care Investments Under Alternative Payment Rules
  119. Shifting the Risk in Pricing and Reimbursement Schemes? A Model of Risk-Sharing Agreements for Innovative Drugs
  120. Patient Mobility, Health Care Quality and Welfare
  121. Delay is Not the Answer: Waiting Time in Health Care & Income Redistribution
  122. Devolution in the Provision of Merit and Impure Public Goods: Who Gains, Who Loses
  123. A Note on Optimal Tax Evasion in the Presence of Merit Goods
  124. THE EFFECT OF DEFICIT IN A MULTICOUNTRY MODEL WITH PERFECT MOBILITY OF CAPITAL
  125. The Regional Organization of Hospital Care in Italy: The Effects of Asymmetry of Information and Soft Budget Constraint Rules
  126. Waiting Time and Public Health Care: A Comment to 'Public Health Care with Waiting Time: The Role of Supplementary Private Health Care'
  127. Pricing and Marketing Strategies of On Line Pharmacies
  128. A Welfare Analysis of Rationing in Health Care Provision
  129. Oligopolistic Competition for the Provision of Hospital Care
  130. Would Less Solidarity Justify Present Calls for Devolution?
  131. Pricing Policies When Patients are Heterogeneous: A Welfare Analysis
  132. Timely, Cheap, or Risk Free? The Effect of Regulation on the Price and the Availability of New Drugs